Lv41
618 积分 2021-12-14 加入
Tu1518 QUANTITATIVE ANALYSIS DEFINES DISTINCT HISTOLOGIC AND FIBER SIGNATURES IN INFLAMMATORY BOWEL DISEASE
27天前
已完结
Transmural healing is significantly associated with prevention of clinical relapse in Crohn’s disease
1个月前
已完结
Long-term retention of adalimumab treatment and associated prognostic factors for 1189 patients with Crohn's disease
2个月前
已完结
Research Communication: Combination Therapy of Upadacitinib With Infliximab, Risankizumab, Ustekinumab or Vedolizumab for Refractory Crohn's Disease: A Descriptive Case Series
2个月前
已完结
Tu1917: REAL-WORLD EFFECTIVENESS OF RISANKIZUMAB FOR PERIANAL CROHN’S DISEASE: A MULTI-CENTER RETROSPECTIVE STUDY
2个月前
已关闭
S3892 Risankizumab Effectiveness in Perianal Crohn’s Disease: A Single Tertiary Care Center Case Series
2个月前
已关闭
S1490 Dose Intensification of Risankizumab for Crohn’s Disease: Access and Outcomes
2个月前
已完结
Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease
4个月前
已完结
Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study
5个月前
已完结
Dihydrocapsaicin attenuates oxidative stress and apoptosis in acute myocardial infarction via promoting Raf-1/ASK1 complex formation
8个月前
已完结
皖公网安备34019202002308
